- Home
- TOPP vs VTVT Comparison
TOPP vs VTVT Comparison
Compare TOPP & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- VTVT
- Stock Information
- Founded
- TOPP 2014
- VTVT 2015
- Country
- TOPP United States
- VTVT United States
- Employees
- TOPP N/A
- VTVT N/A
- Industry
- TOPP
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- TOPP
- VTVT Health Care
- Exchange
- TOPP NYSE
- VTVT Nasdaq
- Market Cap
- TOPP 39.8M
- VTVT 38.8M
- IPO Year
- TOPP 2025
- VTVT 2015
- Fundamental
- Price
- TOPP $2.29
- VTVT $20.20
- Analyst Decision
- TOPP
- VTVT Strong Buy
- Analyst Count
- TOPP 0
- VTVT 1
- Target Price
- TOPP N/A
- VTVT $35.00
- AVG Volume (30 Days)
- TOPP 85.4K
- VTVT 9.0K
- Earning Date
- TOPP 01-01-0001
- VTVT 03-12-2025
- Dividend Yield
- TOPP N/A
- VTVT N/A
- EPS Growth
- TOPP N/A
- VTVT N/A
- EPS
- TOPP 0.02
- VTVT N/A
- Revenue
- TOPP $15,873,843.00
- VTVT $1,000,000.00
- Revenue This Year
- TOPP N/A
- VTVT N/A
- Revenue Next Year
- TOPP N/A
- VTVT N/A
- P/E Ratio
- TOPP $115.13
- VTVT N/A
- Revenue Growth
- TOPP N/A
- VTVT 11011.11
- 52 Week Low
- TOPP $1.63
- VTVT $8.10
- 52 Week High
- TOPP $4.50
- VTVT $30.99
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- VTVT 63.15
- Support Level
- TOPP N/A
- VTVT $19.02
- Resistance Level
- TOPP N/A
- VTVT $20.89
- Average True Range (ATR)
- TOPP 0.00
- VTVT 1.15
- MACD
- TOPP 0.00
- VTVT 0.30
- Stochastic Oscillator
- TOPP 0.00
- VTVT 68.18
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.